<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pretrained Joint Predictions for Scalable Batch Bayesian Optimization of Molecular Designs - Health AI Hub</title>
    <meta name="description" content="This paper presents a novel approach utilizing Epistemic Neural Networks (ENNs) with pretrained prior networks to enhance Batch Bayesian Optimization (Batch BO)">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Pretrained Joint Predictions for Scalable Batch Bayesian Optimization of Molecular Designs</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.10590v2" target="_blank">2511.10590v2</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-13
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Miles Wang-Henderson, Benjamin Kaufman, Edward Williams, Ryan Pederson, Matteo Rossi, Owen Howell, Carl Underkoffler, Narbe Mardirossian, John Parkhill
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.10590v2" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.10590v2" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper presents a novel approach utilizing Epistemic Neural Networks (ENNs) with pretrained prior networks to enhance Batch Bayesian Optimization (Batch BO) for molecular design. By obtaining scalable joint predictive distributions of binding affinity, the method significantly accelerates the discovery of potent drug candidates. It demonstrates its efficacy by reducing iterations needed to rediscover EGFR inhibitors and find potent small-molecule inhibitors from real-world libraries, offering a promising solution for large-scale drug discovery.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This work directly impacts drug discovery and development by providing a computational method that significantly accelerates the identification of novel molecular designs with desired binding affinities. This can reduce the time, cost, and experimental burden in the early stages of drug development, potentially speeding up the availability of new therapeutic agents.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>This research applies AI (specifically, pretrained joint predictions and scalable Batch Bayesian Optimization with Epistemic Neural Networks) to accelerate the computational discovery and optimization of molecular designs for drug development. It uses AI models as surrogates to predict binding affinity, thereby reducing the need for extensive physical synthesis and testing iterations in drug discovery, as demonstrated by finding potent EGFR inhibitors.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the key bottleneck of batched synthesis and testing in molecular design by improving probabilistic surrogates for binding affinity.</li>
                    
                    <li>Introduces Epistemic Neural Networks (ENNs) to generate scalable joint predictive distributions of binding affinity, leveraging representations from large structure-informed biomolecular foundation models.</li>
                    
                    <li>Highlights the crucial role of prior networks within ENNs and details a strategy to pretrain them on synthetic data to enhance downstream Batch BO performance.</li>
                    
                    <li>The method demands parallel acquisition functions that hedge between designs and the ability to rapidly sample from a joint predictive density.</li>
                    
                    <li>Achieved rediscovery of known potent EGFR inhibitors on a semi-synthetic benchmark in up to 5x fewer iterations.</li>
                    
                    <li>Successfully identified potent inhibitors from a real-world small-molecule library in up to 10x fewer iterations.</li>
                    
                    <li>Offers a scalable and promising solution for accelerating large-scale drug discovery applications by drastically reducing experimental cycles.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The methodology leverages Epistemic Neural Networks (ENNs) built upon representations derived from large structure-informed biomolecular foundation models. A central innovation is the investigation and pretraining of 'prior networks' within these ENNs using synthetic data. This framework enables the generation of scalable joint predictive distributions of binding affinity, which are critical for approximating parallel acquisition functions in Batch Bayesian Optimization (Batch BO) to efficiently select molecular designs for synthesis and testing.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The proposed method demonstrated significant acceleration in molecular design, leading to the rediscovery of known potent EGFR inhibitors on a semi-synthetic benchmark in up to 5x fewer iterations. Furthermore, it successfully identified potent inhibitors from a real-world small-molecule library in up to 10x fewer iterations, showcasing its practical utility and efficiency.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>By drastically reducing the number of experimental iterations required for identifying potent drug candidates, this technology can significantly accelerate the preclinical phase of drug development. This could lead to a faster pipeline for bringing novel drugs to market, potentially providing quicker access to new treatments for various diseases and lowering the overall cost of drug development.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The provided abstract does not explicitly state any specific limitations of the methodology or the presented results.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly mention specific future research directions, beyond positioning the work as a 'promising solution for large-scale drug discovery applications,' implying continued development and scaling.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Drug Discovery</span>
                    
                    <span class="tag">Pharmaceutical Research</span>
                    
                    <span class="tag">Medicinal Chemistry</span>
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Oncology (specifically for EGFR inhibitors)</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Batch Bayesian Optimization</span>
                    
                    <span class="tag tag-keyword">Epistemic Neural Networks</span>
                    
                    <span class="tag tag-keyword">molecular design</span>
                    
                    <span class="tag tag-keyword">drug discovery</span>
                    
                    <span class="tag tag-keyword">binding affinity</span>
                    
                    <span class="tag tag-keyword">foundation models</span>
                    
                    <span class="tag tag-keyword">pretrained networks</span>
                    
                    <span class="tag tag-keyword">scalable surrogates</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Batched synthesis and testing of molecular designs is the key bottleneck of drug development. There has been great interest in leveraging biomolecular foundation models as surrogates to accelerate this process. In this work, we show how to obtain scalable probabilistic surrogates of binding affinity for use in Batch Bayesian Optimization (Batch BO). This demands parallel acquisition functions that hedge between designs and the ability to rapidly sample from a joint predictive density to approximate them. Through the framework of Epistemic Neural Networks (ENNs), we obtain scalable joint predictive distributions of binding affinity on top of representations taken from large structure-informed models. Key to this work is an investigation into the importance of prior networks in ENNs and how to pretrain them on synthetic data to improve downstream performance in Batch BO. Their utility is demonstrated by rediscovering known potent EGFR inhibitors on a semi-synthetic benchmark in up to 5x fewer iterations, as well as potent inhibitors from a real-world small-molecule library in up to 10x fewer iterations, offering a promising solution for large-scale drug discovery applications.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>